Global cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's
Gian Pal1,2, Joan O'Keefe3,4, Erin Robertson-Dick4
1Department of Neurological Sciences, Rush University, Chicago, IL, USA. gian_d_pal@rush.edu.
Journal of Neuroengineering and Rehabilitation
|October 30, 2016
Summary
Global cognitive function in Parkinson's disease (PD) is linked to gait speed and turning. Reduced processing speed specifically correlates with greater difficulty in turning for PD patients.
Area of Science:
- Neuroscience
- Gerontology
- Movement Disorders
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor control.
- Cognitive impairment is common in PD and impacts daily functioning.
- Understanding the link between cognition and motor performance is crucial for PD management.
Purpose of the Study:
- To investigate the relationship between global cognitive function and specific gait and balance parameters in Parkinson's disease patients.
- To determine if specific cognitive domains correlate with gait and balance performance in this cohort.
Main Methods:
- Fourteen Parkinson's disease patients underwent motor, gait, and balance assessments.
- Quantitative gait and balance data were collected using the APDM Mobility Lab™ system.
- Global and domain-specific cognitive tests were administered, with Spearman's rho and FDR correction used for correlation analysis.
Main Results:
- Global cognitive function strongly correlated with stride velocity, turn duration, steps to turn, and postural sway.
- Processing speed showed a significant association with turning measures (turn duration and steps to turn).
- No other significant associations were found between specific cognitive domains and gait domains.
Conclusions:
- This pilot study suggests a link between global cognitive function and pace-related gait and balance measures in Parkinson's disease.
- Impaired processing speed is associated with difficulties in turning among PD patients.
- Further research is warranted to explore these associations in larger cohorts.
Related Concept Videos
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K


